A renal clearable fluorogenic probe for in vivo β-galactosidase activity detection during aging and senolysis.
Sara Rojas-VázquezBeatriz Lozano-TorresAlba García-FernándezIrene GalianaAna Perez-VillalbaPablo Martí-RodrigoM José PalopMarcia DomínguezMar OrzáezFélix SancenónJuan F BlandezIsabel FariñasRamón Martínez-MáñezPublished in: Nature communications (2024)
Accumulation of senescent cells with age leads to tissue dysfunction and related diseases. Their detection in vivo still constitutes a challenge in aging research. We describe the generation of a fluorogenic probe (sulfonic-Cy7Gal) based on a galactose derivative, to serve as substrate for β-galactosidase, conjugated to a Cy7 fluorophore modified with sulfonic groups to enhance its ability to diffuse. When administered to male or female mice, β-galactosidase cleaves the O-glycosidic bond, releasing the fluorophore that is ultimately excreted by the kidneys and can be measured in urine. The intensity of the recovered fluorophore reliably reflects an experimentally controlled load of cellular senescence and correlates with age-associated anxiety during aging and senolytic treatment. Interestingly, our findings with the probe indicate that the effects of senolysis are temporary if the treatment is discontinued. Our strategy may serve as a basis for developing fluorogenic platforms designed for easy longitudinal monitoring of enzymatic activities in biofluids.
Keyphrases
- living cells
- fluorescent probe
- induced apoptosis
- hydrogen peroxide
- type diabetes
- photodynamic therapy
- loop mediated isothermal amplification
- nitric oxide
- label free
- physical activity
- cell death
- adipose tissue
- cell cycle arrest
- cross sectional
- metabolic syndrome
- signaling pathway
- depressive symptoms
- skeletal muscle
- endoplasmic reticulum stress
- replacement therapy
- sleep quality
- insulin resistance